AnHeart Therapeutics Inc. clinical trials
Acquired by Nuvation Bio Inc., Apr 9, 2024 · source ↗
The registry lists 1 studies whose lead sponsor is AnHeart Therapeutics Inc.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 18, 2024.
- 1study on the registry
- 0open to participants now
Before and after it joined Nuvation Bio Inc.
- First submitted before AnHeart Therapeutics Inc. became part of Nuvation Bio Inc.
- 1
- First submitted after AnHeart Therapeutics Inc. became part of Nuvation Bio Inc.
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
What it is testing
The drugs AnHeart Therapeutics Inc.’s studies test, most studies first; none is open now — 1 drug with a page of their own. Each count opens the studies in search.
Studies, none open
- 0 open · 1
All 1 at a glance
Where each study is in its life, its phase and its countries. Each count opens them in search.
- Stopped early1100%
Over the years
- 123
- 24
- 25
- 026
By the year each study started. 2026 so far in the lighter column.
Registry sponsor names on this page
- AnHeart Therapeutics Inc.1 study
Something wrong with this grouping? Tell us on the Nuvation Bio Inc. page.
Studies
Recruiting first, then most recently updated. Showing 1 of 1. All Nuvation Bio Inc. studies →
- IDH1 Inhibitor AB-218 in Patients With Advanced IDH1 Mutant Cholangiocarcinoma and Other Solid TumorTerminatedNCT05814536Phase 1
Sponsor listed in the registry: AnHeart Therapeutics Inc. · First submitted before AnHeart Therapeutics Inc. became part of Nuvation Bio Inc.